Influence of exogenous RARα gene on MDR1 expression and P-glycoprotein function in human and rodent cell lines

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 1718-1725

  Stromskaya, T P ^a   Rybalkina, E Y ^a   Shtil, A A ^b   Zabotina, T N ^a   Filippova, N A ^b   Stavrovskaya, A A ^a,c  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Cancer Research Center   (Russian Federation)

Author keywords

Differentiation; Gene expression; Multidrug resistance; P glycoprotein; Retinoic acid receptor

Indexed keywords

ALPHA FETOPROTEIN; COLCHICINE; COMPLEMENTARY DNA; CYTOTOXIC AGENT; GLYCOPROTEIN P; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG TRANSPORT; GENE TRANSFER; HEPATOMA CELL; HUMAN; HUMAN CELL; MELANOMA CELL; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR GENE; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION;

EID: 0031800527     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.288     Document Type: Article

References (32)

1. Alekseevskaya OD, Anfimova ML, Djuraeva FH, Somova OV, Stavrovskaya AA, Stromskaya TP, Shtil AA and Eraizer TL (1993) Alteration of embryo-specific proteins expression in the multidrug-resistant cells (in Russian). Herald Cancer Res Center 2: 21-30
2. Bates SE, Mickley LA, Chen YN, Riehert N, Rudick J, Biedler JL and Fojo AT (1989) Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation. Mol Cell Biol 9: 4337-4344
3. Beck WT and Danks M (1991) Characteristics of multidrug resistance in human tumor cells. In Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, Roninson IB (ed), pp. 3-55. Plenum Press: New York
4. Becker J, De Nechaud B and Potter VP (1976) Two new rat hepatoma cell lines for studying the unbalanced blocked ontogeny hypothesis. In Onco-Developmenlal Gene Expression, Fishman WH and Sell S (eds), pp 259-270, Academic Press: New York
5. Biedler JL and Spengler BA (1994) Reverse transformation of multidrug resistant cells. Cancer Metastas Rev 13: 191-207
6. Chaudhary PM and Roninson IB (1992) Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonist. Oncology Res 4: 281-290
7. Chaudhary PM and Roninson IB (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapcutic drugs. J Natl Cancer Inst 85: 632-639
8. Chin K-V, Chauhan SS, Pastan I and Gottesman MM (1990a) Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Different 1: 361-365
9. Chin K-V, Tanaka S, Darlington G, Pastan I and Gottesman MM (1990b) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 265: 221-226
10. Chin K-V, Ueda K, Pastan I and Gottesman MM (1992) Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 255: 459-462
11. Collins SJ, Robertson KA and Mueller LeM (1990) Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-α). Mol Cell Biol 10: 2145-2163
12. Djuraeva FH, Stavrovskaya AA and Stromskaya TP (1991) Correlations between multidrug resistance and differentiation in the mouse erythroleucosis (in Russian). Herald Cancer Res Center 4: 7-12
13. Egudina SV, Stromskaya TP, Frolova EA and Stavrovskaya AA (1993) Early steps of P-glycoprotein expression in cell cultures studied with vital fluorochrome. FEBS Letters 329: 63-66
14. Filippova NA, Parshikova SM and Timar E (1983) Ultrastructure of human skin melanomas (in Russian). Arch Patologii 8: 19-25
15. Gottesman MM, Willingham MC, Thiebaut F and Pastan I (1991) Expression of the MDR1 gene in normal human tissues. In Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, Roninson IB (ed), pp. 279-289. Plenum Press, New York
16. Knowles BB, Howe CC and Aden DP (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigene. Science 209: 497-499
17. Kohno K, Sato S, Takano H, Matsuo K-I and Kuwano M (1989) The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun 165: 1415-1421
18. Kopnin BP, Stromskaya TP, Kondratov RV, Ossovskaya VS, Pugacheva EN, Rybalkina EY, Khokhlova OA and Chumakov PM (1995) Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts. Oncol Res 7: 299-306
19. Lehrach J, Diamond D, Wozney J and Boedtker H (1977) RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical examination. Biochemistry 16: 4743-4751
20. Licht T, Ciebig HH, Bross K, Hermann F, Berger DP, Shoemaker R and Sann M (1991) Induction of multidrug resistance during anti-neoplastic chemotherapy in vitro. Int J Cancer 49: 630-637
21. Maniatis T, Fritsch EE and Sambrook J (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Herbor, NY
22. Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N and Fojo AT (1989) Modulation of the expression of a multidrug resistance gene (mdr1/P-glycoprotein) by differentiating agents. J Biol Chem 264: 18031-18040
23. Mishima Y and Imokawa G (1986) Melanoma and melanosome genesis. J Electron Microsc 35 (suppl. 1): 2153-2156
24. Neyfakh AA (1988) Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 174: 168-178
25. Noonan K and Roninson IB (1991) Quantitative estimation of MDR1 mRNA levels by polymerase chain reaction. In Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, Roninson IB (ed), pp. 319-332. Plenum Press: New York
26. Roninson IB (1991) Structure and evolution of P-glycoprotein. In Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, Roninson IB (ed), pp. 189-211. Plenum Press: New York
27. Stavrovskaya AA, Stromskaya TP, Chernova OB and Djuraeva FK (1990) Multidrug-resistance and differentiation in the population of transformed canine kidney cells MDCK (in Russian). Mol Genet Microbiol Virol 5: 3-7
28. Stromskaya TP, Filippova NA, Rybalkina EY, Egudina SV, Shtil AA, Eliseenkova AV and Stavrovskaya AA (1995a) Alterations of melanin synthesis in human melanoma cells selected in vitro for multidrug resistance. Exp Tox Pathol 47: 157-166
29. Stromskaya TP, Grigorian IA, Ossovskaya VS, Rybalkina EY, Chumakov PM and Kopnin BP (1995b) Cell-specific effects of RAS oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEBS Letters 368: 373-376
30. Sugimoto Y and Tsuruo T (1991) Development of multidrug resistance in rodent cells lines. In Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, Roninson IB (ed), pp. 57-70. Plenum Press: New York
31. Teeter LD, Eckersberg T, Tsai Y and Kuo MT (1991) Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgp1 reveals that the AP-1 site is essential for full promoter activity. Cell Growth Differ 2: 429-437
32. van Helvoort A, Smiht AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P and van Meer G (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507-517